Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Saved in:
| Title: | Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. |
|---|---|
| Authors: | Gombos A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. andrea.gombos@bordet.be.; Université Libre de Bruxelles, Brussels, Belgium. andrea.gombos@bordet.be., Venet D; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Ameye L; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Vuylsteke P; Medical Oncology, UCLouvain, CHU Namur Site Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Private Bag UB 0022, Gabarone, Botswana., Neven P; Multidisciplinary Breast Center and Department of Gynecology and Obstetrics, UZ Leuven, KU Leuven, Leuven, Belgium., Richard V; Medical Oncology CHU Ambroise Paré, Mons, Belgium., Duhoux FP; Medical Oncology Cliniques Universitaires Saint-Luc, Brussels, Belgium., Laes JF; OncoDNA, Gosselies, Belgium., Rothe F; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Sotiriou C; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium.; Breast Cancer Translational Research Laboratory, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium., Paesmans M; Statistical Department, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium., Awada A; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Guiot T; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium., Flamen P; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium., Piccart-Gebhart M; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Ignatiadis M; Medical Oncology Department, Institut Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium.; Université Libre de Bruxelles, Brussels, Belgium., Gebhart G; Nuclear Medicine, Institut Jules Bordet, Brussels, Belgium. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2022 Mar 16; Vol. 8 (1), pp. 38. Date of Electronic Publication: 2022 Mar 16. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-022-00409-x |
